Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.
about
Integrated proteomic and metabolic analysis of breast cancer progressionPhysical Confirmation and Comparative Genomics of the Rat Mammary carcinoma susceptibility 3 Quantitative Trait LocusAnti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.Genetic alterations of chromosome 8 genes in oral cancer.MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cellsMethylation of tumor suppressor genes is related with copy number aberrations in breast cancerPrdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.Rationale for targeting fibroblast growth factor receptor signaling in breast cancerInference of tumor phylogenies from genomic assays on heterogeneous samples.Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicineValidity of whole slide images for scoring HER2 chromogenic in situ hybridisation in breast cancer.Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplificationFunctional characterization of the 19q12 amplicon in grade III breast cancersFibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL.BIRC5 Genomic Copy Number Variation in Early-Onset Breast Cancer.Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL)A phylogenetic model for understanding the effect of gene duplication on cancer progressionSomatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers.Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?Clonal profiling of mixed lobular and ductal carcinoma revealed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.Histone Modifications and Cancer.Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?Multiplex Ligation-dependent Probe Amplification Can Clarify HER2 Status in Gastric Cancers with "Polysomy 17".Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.Amplification of chromosome 8 genes in lung cancer.Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification.Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.Chromosome 17 copy number changes in male breast cancer.Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.Multiplex ligation-dependent probe amplification for HER2 testing in breast cancer.Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification.Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes.Achieving 95% cross-methodological concordance in HER2 testing: causes and implications of discordant cases.Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.
P2860
Q28533861-D58F7243-C372-4A5C-BE9D-1CE346A5A62DQ33807637-DD3AA61E-3813-46E0-A023-2ACADAD7311BQ33829335-EAE68B0B-96C2-49B4-973D-45CEF4742B6FQ34048738-98D86D07-69EB-43A1-BF6A-54942FC41BC1Q34314172-B5291CE0-348F-45FE-AD17-3595EA0939A3Q34991280-962E3DD6-5828-44BE-A054-F27DA786A89DQ35064585-F268BE6E-B44B-4F38-9ACC-8BC7E8D7CA16Q35131258-E30961CF-B7E6-4438-AA1D-1714241CBD19Q35986538-69A3A3C9-BE24-4088-BFD4-2F5A79813431Q35993199-E48ABD03-3430-4EF2-B741-16AD94CF7418Q36012823-52AD22BF-A855-4701-BD70-8CA3D27130D8Q36147178-8583BDF4-C9F2-44BA-82F7-27B166A5C6A4Q36245567-983F9BD5-6085-420F-9441-A5CA5F59A26DQ36801189-0BCA9020-4B78-49AD-8877-AE1C1F9EBA28Q36920819-A09D3CE0-0229-4BE3-9441-AEA051EDD973Q37172715-C02BEA0B-53C4-4499-964C-BD0C0E102FC4Q37269121-63F2A098-5D23-426E-B8ED-4F822D18C1C2Q37287482-82D1279F-3C1A-4654-9508-30E4BE1CEE90Q37631856-91593061-989C-4A90-A015-D4AA4C2E597CQ37687527-16215591-6AC6-4759-858F-1762CE6CB96BQ38212165-9639DCE4-920C-4C36-B1A2-B279850A15DDQ38216902-F712514E-29D7-4303-A9B8-F1C4817AF39FQ38796064-CEA9CA04-6DF2-4B44-B691-52CDB63BDB9FQ38975402-E59EF198-C118-44E2-B291-1C718CE10D31Q39467942-4929F867-D467-44D6-9634-D97AB24B7631Q39664547-56A30669-732F-4532-9F43-9FCDBBE2CD58Q40417660-8EA2D375-E939-4233-A57C-8FEE546299FBQ40581699-239996A8-0374-434B-89E4-98E5FBBBEDBDQ40951473-10243526-22C4-4BB4-B788-28D59A1AADC1Q41837923-1034EC8F-5044-4539-B58A-8AE055CB9A0CQ45342178-8D716453-6A98-4317-9941-6B90D9FC6E1DQ53776269-87566C0F-FEA4-4ACD-84F1-C666DF03796CQ54165077-C15AC285-457C-4E16-A354-7411ACB0FC9EQ54215084-75126EE8-2390-4CF0-AB52-95D23AD0E8E9Q54279108-23CBB8EB-9640-41F4-A2CB-78045452C329Q54342567-538A0017-2AA0-4235-A11B-944BA1D2968FQ54374707-3AF918D2-B0BC-4281-B0E3-F8CE54D9E6A3Q54550048-AC208550-37E0-4FC7-9810-CA25EE862E11Q54660266-A33FC723-9DAC-4247-A054-409FAE582B88Q55223470-76640EBA-A6DA-4089-9248-97DCEE80BEFB
P2860
Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Molecular profiling of invasiv ...... umor suppressor and oncogenes.
@en
Molecular profiling of invasiv ...... umor suppressor and oncogenes.
@nl
type
label
Molecular profiling of invasiv ...... umor suppressor and oncogenes.
@en
Molecular profiling of invasiv ...... umor suppressor and oncogenes.
@nl
prefLabel
Molecular profiling of invasiv ...... umor suppressor and oncogenes.
@en
Molecular profiling of invasiv ...... umor suppressor and oncogenes.
@nl
P2093
P1433
P1476
Molecular profiling of invasiv ...... umor suppressor and oncogenes.
@en
P2093
Hanneke N Monsuur
Paul J van Diest
Raymon Vijzelaar
Roel A de Weger
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.84
P577
2010-05-14T00:00:00Z
P5875
P6179
1024662346